Evidence map›Paper›PMID 39973465›Full record

ArticleJournal of neuromuscular diseases2024

Asymptomatic and oligosymptomatic states of dysferlinopathy.

Sergey N Bardakov, Roman V Deev, Vadim A Tsargush, Vladimir S Kaimonov, Elizaveta V Musatova, Konstantin A Blagodatskikh, Aleksandra A Tveleneva, Yana V Sofronova, Vasiliy M Suslov, Pierre G Carlier and 4 more

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of neuromuscular diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04824040 (Evaluation of Clinical, Immunological, Morphological, Molecular and Genetic Characteristics of Patients With Limb-girdle Muscular Dystrophy Type R2), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04824040 enrolling by invitationnot on this map

Evaluation of Clinical, Immunological, Morphological, Molecular and Genetic Characteristics of Patients With Limb-girdle Muscular Dystrophy Type R2 (Type 2B) in the Russian Federation

Typeobservational_patient_registrySponsorArtgen BiotechRan2020 to 2027Enrolled100ConditionsDysferlinopathy, Miyoshi Myopathy, LGMDR2, DMAT
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Sergey N BardakovS.M. Kirov Military Medical Academy, St. Petersburg, Russia.
Roman V DeevA.P. Avtsyn Research Institute of Human Morphology of Federal state budgetary scientific institution "Petrovsky National Research Centre of Surgery", Ministry of Science and Higher Education of Russia, Moscow, Russia.
Vadim A TsargushS.M. Kirov Military Medical Academy, St. Petersburg, Russia.
Vladimir S KaimonovBelgorod National Research University, Belgorod, Russiaxs.
Elizaveta V MusatovaBelgorod National Research University, Belgorod, Russiaxs.
Konstantin A BlagodatskikhBelgorod National Research University, Belgorod, Russiaxs.
Aleksandra A TvelenevaBelgorod National Research University, Belgorod, Russiaxs.
Yana V SofronovaBelgorod National Research University, Belgorod, Russiaxs.
Vasiliy M SuslovSaint-Petersburg State Pediatric Medical University, St. Petersburg, Russia.
Pierre G CarlierNeuromuscular Disease Reference Center, University of Liege, and Department of Neurology, St. Luc University Hospital, Brussels, Belgium.
Sergey A KurbatovResearch Institute of Experimental Biology and Medicine, Voronezh N.N. Burdenko State Medical University, Voronezh, Russia.
Ivan A YakovlevArtgen Biotech PJSC, Moscow, Russia.
Zoya R UmakhanovaDagestan State Medical University, Makhachkala, Russia.
Artur A IsaevArtgen Biotech PJSC, Moscow, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dysferlinopathy is a phenotypically heterogeneous, inherited, progressive muscular dystrophy caused by mutations in the

Indexed as

Muscular Dystrophies, Limb-GirdleAdolescentAsymptomatic DiseasesChildChild, PreschoolCreatine KinaseDisease ProgressionDysferlinFemaleHumansL-Lactate DehydrogenaseMagnetic Resonance ImagingMaleMuscle, SkeletalMutationCreatine KinaseDysferlinDYSF protein, humanL-Lactate Dehydrogenaseasymptomatic stateDYSFdysferlinopathyisolated hyperCKemiaoligosymptomatic statequantitative MRIsubclinical status

Identifiers

PMID39973465
PMCPMC13108004

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.